Literature DB >> 12709782

The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression.

Nathalie Niederhoffer1, Karin Schmid, Bela Szabo.   

Abstract

Our objective was to identify the sites of interaction of cannabinoids with cardiovascular sympathetic regulation in the rat. Effects on sympathetic tone were first determined in anaesthetised animals following i.v. administration of the drugs. Central effects were evaluated in anaesthetised rats receiving microinjections of cannabinoids into brain stem nuclei. Peripheral effects were identified in pithed rats with electrically stimulated sympathetic outflow. In anaesthetised and artificially ventilated rats, i.v. injection of the cannabinoid agonists WIN55212-2 and CP55940 decreased mean arterial pressure, heart rate and the plasma noradrenaline concentration. These effects were antagonized by the CB(1) cannabinoid receptor antagonist SR141716A. The bradycardia was abolished by the muscarinic acetylcholine receptor antagonist methylatropine. The decreases in mean arterial pressure and heart rate caused by cannabinoids in ventilated rats were much less pronounced than in spontaneously breathing rats. Microinjection of WIN55212-2 into the nucleus tractus solitarii had no effect. Microinjected into the rostral ventrolateral medulla oblongata, WIN55212-2 lowered mean arterial pressure slightly without changing other parameters. In pithed rats, WIN55212-2 inhibited the increases in mean arterial pressure, heart rate and the plasma noradrenaline concentration evoked by electrical stimulation of the sympathetic outflow. Our results show that activation of CB(1) cannabinoid receptors induces sympathoinhibition and enhancement of cardiac vagal tone, leading to hypotension and bradycardia. Presynaptic inhibition of noradrenaline release from terminals of postganglionic sympathetic neurons is the major component of the sympathoinhibition, but an effect in the rostral ventrolateral medulla oblongata may also contribute. The cannabinoid-evoked cardiovascular depression depends strongly on the respiratory state of the animals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709782     DOI: 10.1007/s00210-003-0755-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.

Authors:  P Mailleux; J J Vanderhaeghen
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

2.  Characterization of the absorption phase of marijuana smoking.

Authors:  M A Huestis; A H Sampson; B J Holicky; J E Henningfield; E J Cone
Journal:  Clin Pharmacol Ther       Date:  1992-07       Impact factor: 6.875

3.  Production and physiological actions of anandamide in the vasculature of the rat kidney.

Authors:  D G Deutsch; M S Goligorsky; P C Schmid; R J Krebsbach; H H Schmid; S K Das; S K Dey; G Arreaza; C Thorup; G Stefano; L C Moore
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

Authors:  K D Lake; D R Compton; K Varga; B R Martin; G Kunos
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

Review 5.  The subretrofacial vasomotor nucleus: anatomical, chemical and pharmacological properties and role in cardiovascular regulation.

Authors:  R A Dampney
Journal:  Prog Neurobiol       Date:  1994-02       Impact factor: 11.685

6.  Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and delta 9-tetrahydrocannabinol in anesthetized cats.

Authors:  P A Doherty; L E McCarthy; H L Borison
Journal:  J Pharmacol Exp Ther       Date:  1983-11       Impact factor: 4.030

7.  Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors.

Authors:  B Malinowska; J Piszcz; B Koneczny; A Hryniewicz; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-09       Impact factor: 3.000

Review 8.  Cardiovascular effects of endocannabinoids--the plot thickens.

Authors:  G Kunos; Z Járai; K Varga; J Liu; L Wang; J A Wagner
Journal:  Prostaglandins Other Lipid Mediat       Date:  2000-04       Impact factor: 3.072

9.  Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.

Authors:  N Niederhoffer; B Szabo
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

10.  Cardiovascular and respiratory effects of cannabis in cat and rat.

Authors:  J D Graham; D M Li
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

View more
  37 in total

Review 1.  The complexities of the cardiovascular actions of cannabinoids.

Authors:  Michael D Randall; David A Kendall; Saoirse O'Sullivan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats.

Authors:  Grzegorz Godlewski; Barbara Malinowska; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

Review 3.  Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?

Authors:  Barbara Malinowska; Marta Baranowska-Kuczko; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.

Authors:  Grzegorz Godlewski; Shakiru O Alapafuja; Sándor Bátkai; Spyros P Nikas; Resat Cinar; László Offertáler; Douglas Osei-Hyiaman; Jie Liu; Bani Mukhopadhyay; Judith Harvey-White; Joseph Tam; Karel Pacak; Jacqueline L Blankman; Benjamin F Cravatt; Alexandros Makriyannis; George Kunos
Journal:  Chem Biol       Date:  2010-11-24

Review 5.  Regulation of bone remodeling by the central and peripheral nervous system.

Authors:  Florent Elefteriou
Journal:  Arch Biochem Biophys       Date:  2008-03-23       Impact factor: 4.013

6.  Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.

Authors:  Torsten Pfitzer; Nathalie Niederhoffer; Bela Szabo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-01-20       Impact factor: 3.000

Review 7.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

8.  Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors.

Authors:  S Grassin-Delyle; E Naline; A Buenestado; C Faisy; J-C Alvarez; H Salvator; C Abrial; C Advenier; L Zemoura; P Devillier
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

9.  Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.

Authors:  María del Carmen García; Edda Adler-Graschinsky; Stella Maris Celuch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-18       Impact factor: 3.000

10.  Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients.

Authors:  Christopher T Dibble; Eli V Gelfand; Christopher P Cannon
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.